The role of TNF in autoimmune and inflammatory diseases is well established and well documented. Our TNF-driven animal models provide a unique tool to evaluate the efficacy of therapeutics targeting TNF, or other molecules implicated in the pathogenesis of immunological diseases. These transgenic models, mostly humanized (i.e created with human genes), develop chronic polyarthritis, inflammatory bowel disease, cachexia and multiple sclerosis.